CRYPTOCOCCAL ANTIGEN LATERAL FLOW ASSAY, IMMY, Lateral Flow Assay for the Detection of Cryptococc...

FDA Device Recall #Z-0545-2022 — Class II — January 3, 2022

Recall Summary

Recall Number Z-0545-2022
Classification Class II — Moderate risk
Date Initiated January 3, 2022
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Immuno-Mycologics, Inc
Location Norman, OK
Product Type Devices
Quantity 411 kits

Product Description

CRYPTOCOCCAL ANTIGEN LATERAL FLOW ASSAY, IMMY, Lateral Flow Assay for the Detection of Cryptococcal Antigen in serum and CSF, REF CR2003, IVD, UDI: (01)00816387020919

Reason for Recall

The firm found immunoassay products used to detect cryptococcal antigen in serum and cerebrospinal fluid to have reduced specificity (90% now versus 99% before). As a result, a small number of samples with positive test results may be false positives, which may cause some patients to initiate unnecessary anti-fungal therapy. Samples with negative test results are NOT affected.

Distribution Pattern

US Nationwide distribution in the states of AL, AR, AZ, CA, CO, CT, FL, GA, IL, IN, KY, LA, MA, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NM, NY, OH, OR, PA, RI, SC, TN, TX, UT, VA, WA.

Lot / Code Information

F1021035 and F1021036

Other Recalls from Immuno-Mycologics, Inc

Recall # Classification Product Date
Z-1389-2025 Class II Candida ID Antigen, REAG, AG, REF C50110, Vol 1... Feb 10, 2025
Z-2301-2020 Class II Histoplasma Immunodiffusion (ID) Antigen; The I... Nov 4, 2019
Z-2409-2018 Class II Cryptococcal Antigen Lateral Flow Assay (CrAg L... Mar 30, 2018
Z-1109-2017 Class II Cryptococcal Antigen Lateral Flow Assay (CrAg L... Dec 27, 2016
Z-2040-2016 Class II Histoplasma Yeast Complement Fixation Antigen D... May 9, 2016

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.